Search results

Technically its not on otcbb. Its a nasdaq listed stock, though it does on "average" trade under 1MM shares a day. A lot of interesting equities do under a 1MM ADV. A lot of what I was taught and have learned over the years is that the oppurtunity comes from these areas that the funds over...

Always do your DD, Adam F. is a former lifestyles writer, who wasn't even allowed into certain oncology conferences. He is not in the least credible. He is biased and there is a reason why the articles on the street.com are free, and its not the quality. I'll take the wall street journal and...

Numbers are deceiving. You make a good point though. I won't go into it publicly, but PM me if your curious about my counterpoint, and I will tell you how to determine if a company is a target for a naked short campaign even if its not on the Reg SHO list. Its been determined more than the...

Maybe Flippant was a little harsh. I retract the statement, just seemed you were coming across to me as a little jaded in your outlook and presentation. Yes it could be a good "momo" play as it will take multiple days after an initial gap to cover FTD shares that are not readily available...

You almost had it... Your code was missing the Embed src= (Cover your ears before clicking below) http://www.htmlcodetutorial.com/embeddedobjects/_EMBED.html Heres what you wanted. <object width="425" height="344"><param name="movie"...

I'll chime in.. If you don't recognize it, its from the 80's movie wallstreet. Reminds me to always cover all my bases. As this was the song right before his fall from grace. <object width="425" height="344"><param name="movie"...

Right, thats real intelligent advice. Short it and then wait for the news or big contract/acquisition. I'm sure there will be plenty of room for all naked shorts to get out before an overnight gap. Biotech's are a fairly neglected area of the market, by the time the spotlight hits the entry is...

Amen, enforcing a balance of supply and demand of the supposedly limited shares of the company, what a concept. :eek:

Thread scrubbed, you may resume on topic...

Looks like the shows starting early.. http://www.bloomberg.com/apps/news?pid=conewsstory&refer=conews&tkr=INGN%3AUS&sid=ax3jcQVuZOrc Was not expecting them to hear back from europe for a few more weeks.

Throw out the names you like and why.

Good point. Seems they were approached before, but they thought the bid undervalued the pipeline. Also they were in a legal battle with a little company you might have heard of called Schering-Plough over patents. They won that fight, but the drug was so lucrative a chinese company called...

Checked the Bio. He may be a good pharmacist, but what does he know about oncology? It seems in that snippet he just regurgitates what Adam F. says. just seems like a way to add content to his blog for hits and recognition. This is the same cycle IMCL and Erbitux went through in the 90's...

God bless Texas

sounds like a gann fan..http://www.metaquotes.net/techanalysis/linestudies/gann_fan

I don't post calls publicly often... This is a message for the fund mangers and traders on here that employ a strategy of squeezing naked shorts by accumulating a position once its deemed another funds cost average has become to low from an exhausted short campaign. This method has done...

Because if its naked there is a distortion of supply. If its legitimate thats one thing. If over the float is short, thats just ridiculous. The sooner the new tougher legislation comes out about the (Naked) short selling the better.

Classic

How would anyone know this data :confused: